Back to the beginning: restarting infliximab in inflammatory bowel disease patients with prior loss of response

Clin Gastroenterol Hepatol. 2014 Sep;12(9):1482-4. doi: 10.1016/j.cgh.2014.04.011. Epub 2014 Apr 13.

Authors

Andres J Yarur¹, Maria T Abreu²

Affiliations

¹ Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.
² Center for Crohn's and Colitis, Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.

PMID: 24735794
DOI: 10.1016/j.cgh.2014.04.011

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies / blood*
Antibodies, Monoclonal / immunology*
Antibodies, Monoclonal / pharmacokinetics*
Female
Humans
Immunologic Factors / immunology*
Immunologic Factors / pharmacokinetics*
Inflammatory Bowel Diseases / drug therapy*
Infliximab
Male
Pregnancy

Substances

Antibodies
Antibodies, Monoclonal
Immunologic Factors
Infliximab